Home » Posts tagged 'opm' (Page 2)
Tag Archives: opm
Small cap awards 2016
Company of the year
Bioventix (BVXP)
Bioventix develops and supplies sheep monoclonal antibodies for clinical diagnostic applications. Bioventix originally joined ISDX (Plus-quoted) in 2010 at a share price of 198p and then moved to AIM in April 2014. The share price is more than five times the original flotation price in 2010.
The antibodies can be used in tests for specific ailments and illnesses and it can take one year to develop an antibody for a specific diagnostic test. Customers include Roche, Abbott and Siemens. The majority of revenues come in the form of royalties based on the number of tests using the company’s antibodies. Two antibodies, used in tests for heart failure and vitamin D levels, accounted for nearly three-fifths of revenues in 2014-15. Newer antibodies should help to reduce the dependence on a limited number of products, while one licensing deal with a major customer for one of the two main revenue generators ends in 2017. The vitamin D-related product is expected to continue to grow in importance.
The business is highly cash generative and Bioventix has a progressive dividend policy – this year the dividend is expected to increase from 32.6p a share to 40.2p a share. Pre-tax profit is expected to improve from £3.1m to £3.6m in the year to June 2016.
IPO of the year
Bilby (BILB)
Bilby joined AIM during March 2015 with plans to build a business focused on gas installation, maintenance, electrical, water and building services. The customer base is local authorities and social housing organisations in London and the south east. The initial acquisition at the time of the flotation was gas installation specialist P&R Installation and Bilby subsequently bought Purdy Contracts, which provides electrical services, for £8.07m.
Safety concerns mean that local authorities and housing associations need to spend money on repairing and maintaining gas boilers and pipes. Bilby has a strong position in the gas installation and services market and it can use this to build up revenues from its customer base in other specialisations.
Earlier this year, Bilby made two further add-on acquisitions providing gas and building services for social housing and local authorities. DCB, which will cost up to £4m, provides refurbishment, maintenance and disabled adaptation services in south east England. Spokemead Maintenance provides electrical and repair services and will cost up to £8.7m. A placing raised £5m at 118p a share. Via this placing, ISDX-quoted Western Selection (WESP) invested a further £545,000 and owns 5.9% of Bilby.
P&R has won preferred bidder status for gas support work for the South East Consortium, which is a group of housing associations that manage more than 140,000 residential properties. This framework agreement starts in 2016 and lasts for four years. It could contribute £7m to revenues in 2016-17 and the margin may be better than other work. A full year profit of £3.09m is forecast, rising to £4.88m in 2016-17.
Impact company of the year
Ashley House (ASH)
Care housing and health properties developer Ashley House joined the Social Impact segment of ISDX in February but it retained its AIM quotation. Ashley House moved from ISDX (Plus-quoted) to AIM in January 2007.
Ashley House developed its first GP surgery in 1991 and it provides services to help to resource, fund, community healthcare and supported living properties. The properties are energy efficient. There is a pipeline of 32 schemes with a value of £186.7m, with the vast majority of this pipeline relating to supported living properties. This is despite the fact that there has been uncertainty about housing benefit. Ashley House blames a lack of government funding for the rentals on healthcare properties for the slowdown in activity in this part of the business since 2010.
In the six months to October 2015, revenues jumped from £5.6m to £10.6m and went from a loss to a small profit. Net debt was £2.6m at the end of October 2015. The company has £10.7m of tax losses. A full year profit of £1.1m is forecast, rising to £1.5m in 2016-17.
Executive director of the year
John McArthur – Tracsis (TRCS)
Transport optimisation services and software provider Tracsis has a strong growth record and has got into good habits, such as beating its broker’s forecasts, and that is reflected by the premium rating. John McArthur has guided the company as its chief executive since it floated at a market capitalisation of £7m at 40p a share back in 2007. The share price has risen by more than 1,000% and the company is currently valued at around £127m.
Tracsis made solid progress at the interim stage but it is expected to do much better in the second half thanks to higher contributions from last year’s acquisitions Ontrac and SEP Events, which provides events management and parking services and is second-half weighted. In the six months to January 2016, revenues increased by 19% to £14.3m, organic growth was 7%, with adjusted pre-tax profit flat at £3.2m, excluding the Australian business sold in the period. The growth came in the software and consulting operations. Sales of remote condition monitoring equipment remain flat because of a lack of demand from framework agreements. There is potential for significant sales in the US but this will not contribute in the short term.
The interim dividend was raised by one-quarter to 0.5p a share but that will not put much of a dent in the cash pile of £8m. That cash figure was reduced due to acquisition spending but it should grow until there are additional acquisitions. Full-year profit is expected to improve from £5.6m to £6.8m.
Transaction of the year
1PM (OPM) acquisition of Academy Leasing
Small business finance provider 1PM is growing rapidly on the back of the lack of lending by banks to the smaller end of the market and it has still managed to keep bad debts low. Academy Leasing was acquired for up to £12m at the end of last August. This is the company’s first major acquisition. 1PM has been growing its profit for six years having recovered from the downturn in 2008 and the strategy is to treble the market capitalisation of the business to £100m.
Warrington-based Academy provides finance for the acquisition of equipment with the leads coming from the equipment suppliers. The strategy is to provide finance for every opportunity but riskier opportunities tend to be broked-on in return for commission.
The businesses have been integrated and the management team rationalised, with the former chief executive of 1PM leaving. The chairman Ian Smith has become chief executive with three main executive directors reporting to him. These three cover sales and marketing, strategy and risk and finance. The first two came from Academy.
More recently, 1PM acquired Bradgate, which provides finance for businesses buying construction, recycling and haulage equipment, for up to £2.75m and a book of receivables for £1.6m. Full year profit is expected to nearly double to £3.1m but more importantly earnings per share are forecast to improve from 3.7p to 5.1p.
Alternative financing deal of the year
Capital for Colleagues (CFCP)
ISDX-quoted Capital for Colleagues provides finance that helps employees to invest in the businesses they work for. Last year, Capital for Colleagues raised £302,000 at 59p a share from a crowdfunding campaign via CrowdBnk. The minimum target was £250,000.
Capital for Colleagues raised £2.19m at 50p a share when it joined ISDX on 17 March 2014 and last August it became a member of the Social Stock Exchange. The company has investments in 14 employee-owned businesses, as well as a portfolio of quoted shares in companies’ that have significant employee involvement. Subsidiary C4C Ownership Partners provides advice and support to employee-owned businesses or companies looking to turn themselves into an employee-owned business.
Capital for Colleagues invested £770,000 in employee owned businesses in the six months to February 2016. Interim revenues grew from £257,000 to £364,000 but admin costs increased significantly so, excluding unrealised gains, the pre-tax profit dipped from £41,000 to £34,000. Unrealised gains slumped from £47,000 to £6,000. The net asset value was £4.2m at the end of February 2016 and £1.15m has been raised at 59p a share since then. There are still plenty of opportunities for new investments as well as additional investment in existing investee companies.
Analyst of the year
Charles Hall – Peel Hunt
Journalist of the year
Simon Thompson – Investors Chronicle
Adviser of the year
Zeus Capital
Fund manager of the year
Conor McCarthy and Darren Freemantle, MFM Techinvest Special Situations
Daily Actions – UK Main & AIM market 18022016
Daily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.
AIM Market
ST Rec. changed | ||
From | To | |
Basic Resources | ||
Solgold | Buy | Neutral |
Stellar Diamonds | Buy | Neutral |
Financial Services | ||
IPM | Neutral | Buy |
ADVFN | Buy | Strong Buy |
Amphion Innovations | Neutral | Buy |
Manx Financial | Neutral | Buy |
Fairpoint Group | Neutral | Buy |
First Property Group | Neutral | Buy |
H&T Group | Neutral | Buy |
Lighthouse Group | Neutral | Buy |
Public Services Properties Investments | Buy | Neutral |
Industrial Good & Services | ||
Augean | Buy | Neutral |
Croma Security Solution Group | Neutral | Buy |
Hargreaves Services | Neutral | Buy |
Transense Technologies | Buy | Neutral |
Media | ||
Mirada | Buy | Neutral |
Oil & Gas – Explorers | ||
Rockhopper Exploration | Neutral | Buy |
Oil & Gas – Producers | ||
KBC Advanced Technologies | Neutral | Sell |
Northern Petroleum | Buy | Neutral |
PetroCeltic International | Neutral | Buy |
Technology | ||
DDD Group | Buy | Neutral |
Travel & Leisure | ||
Tasty | Neutral | Buy |
Main Market
ST Rec. changed | ||
From | To | |
Chemicals | ||
Victrex | Buy | Neutral |
Engineering & Machinery | ||
Vesuvius | Buy | Neutral |
Vitec Group | Neutral | Buy |
Leisure & Hotels | ||
Mitchells & Butlers | Buy | Neutral |
Mining | ||
Lonmin | Buy | Neutral |
Personal Care & Household Products | ||
PZ Cussons | Buy | Neutral |
Reckitt Benckiser Group | Sell | Neutral |
Real Estate – REIS | ||
CLS Holdings | Buy | Neutral |
Software & Computer Services | ||
Aveva Group | Buy | Neutral |
Fidessa Group | Neutral | Sell |
Support Services | ||
AMEC Foster Wheeler | Buy | Neutral |
Bunzl | Sell | Neutral |
Shanks Group | Neutral | Buy |
Utilities | ||
Centrica | Neutral | Buy |
RISK WARNING
Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com
The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.
DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.
The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK. Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth. Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors. No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company. Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise. Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules. Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance. Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW. |
1PM (OPM) – Continuing To Beat Expectations
1PM has established an enviable record of persistent growth. Strong trading momentum and high levels of demand mean that results for the half year to 30th November will again be ahead of management expectations. The results will include a contribution from Academy Leasing for the period from 25th August to 30th November which will themselves be ahead of management expectations at the the time of the acquisition.
The company is a specialist provider of finance facilities to the SME sector and its shares have added 9% today in response to the news update. The shares began 2015 at a price of 60p and then rose to 78p before falling back to 63p, followed by todays rise to 71p.
The half year saw £9.7m of new lease and HP contracts, up from £5.8m in 2014, plus a sixfold growth in business loans.
In the year to 31st May revenue was up by 31%, profit before tax by 20% and a maiden final dividend of 0.35p was approved. In the previous year revenue had risen by 35.6% and profit before tax by 73%.
The highest the shares have been was 84p in the summer of 2014.
Interim results are due to be announced in the week commencing 25th January.
Looking for villas and houses for sale in Greece – visit; http://www.hiddengreece.net